Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

GOLGA2/GM130, cis-Golgi Matrix Protein, is a Novel Target of Anticancer Gene Therapy

26 Jun 2012

Abstract excerpt

Achievement of long-term survival of patients with lung cancer treated with conventional chemotherapy is still difficult for treatment of metastatic and advanced tumors. Despite recent progress in investigational therapies, survival rates are still disappointingly low and novel adjuvant and systemic therapies are urgently needed. A recently elucidated secretory pathway is attracting considerable interest as a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autophagy in Disease and Therapy
Share to Cellular transport and secretion
Share to Endoplasmic Reticulum Stress and Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22735382
DOI: 10.1038/mt.2012.125

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

GOLGA2/GM130, cis-Golgi Matrix Protein, is a Novel Target of Anticancer Gene TherapyPMID 22735382Read ↗

Shedding of GPP130 by PC7 and Furin: Implication in Lung Cancer ProgressionSemantic proximity Read ↗

The functional landscape of Golgi membrane protein 1 (GOLM1) phosphoproteome reveal GOLM1 regulating P53 that promotes malignancySemantic proximity Read ↗

Golgicide A induces pyroptosis of lung cancer stem cells by regulating dTGN formation via GOLPH3/MYO18A complexSemantic proximity Read ↗

Downregulation of GFPT2 enhances cisplatin chemotherapy sensitivity in STK11/KRAS mutant non-small cell lung cancer by regulating the hexosamine biosynthesis pathway, resisting tumor growth.Semantic proximity Read ↗

gp130: a promising drug target for cancer therapySemantic proximity Read ↗

Dance of The Golgi: Understanding Golgi Dynamics in Cancer MetastasisSemantic proximity Read ↗

Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells.Semantic proximity Read ↗

Ganglioside G(D2) in small cell lung cancer cell lines: enhancement of cell proliferation and mediation of apoptosis.Semantic proximity Read ↗

The Role of Non-Human Sialic Acid Neu5Gc-Containing Glycoconjugates in Human Tumors: A Review of Clinical and Experimental EvidenceSemantic proximity Read ↗

Leucine-Rich Alpha-2-Glycoprotein1 Gene Interferes with Regulation of Apoptosis in Leukemia KASUMI-1 CellsSemantic proximity Read ↗

The expression alteration of<i>Golim4</i>(Gpp130) and its prognostic value in epithelial ovarian cancerSemantic proximity Read ↗

Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC TherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.